Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Kazuki Nakagita"'
Autor:
Yutaro Mukai, Kyoichi Wada, Koji Miyamoto, Kazuki Nakagita, Mai Fujimoto, Kouichi Hosomi, Takeshi Kuwahara, Mitsutaka Takada, Kengo Kusano, Akira Oita
Publikováno v:
Journal of Arrhythmia, Vol 33, Iss 5, Pp 434-439 (2017)
Background: The periprocedural protocol for atrial fibrillation (AF) ablation commonly includes anticoagulation therapy. Apixaban, a direct oral anticoagulant, is currently approved for clinical use; however, little is known about the effects of resi
Externí odkaz:
https://doaj.org/article/0779fe7e3885426cb89839ff6f93671c
Autor:
Mai, Otokubo, Kyoichi, Wada, Megumi, Ikura, Kotoka, Hayase, Takaya, Uno, Kazuki, Nakagita, Naoki, Hayakawa, Takuya, Watanabe, Osamu, Seguchi, Norihide, Fukushima, Tsutomu, Nakamura
Publikováno v:
Biological and Pharmaceutical Bulletin. 45:452-459
The aim of this study was to investigate whether low-dose valganciclovir (VGCV) prophylaxis for cytomegalovirus (CMV) infection increased the risk of developing neutropenia in heart transplant recipients (HTRs). Forty-three HTRs receiving VGCV were d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::415f84e1af9ba3af9daf01a40e1c4746
https://doi.org/10.1248/bpb.b21-00860
https://doi.org/10.1248/bpb.b21-00860
Autor:
Seiko Nakajima, Masanobu Yanase, Satsuki Fukushima, Sachi Matsuda, Toshimitsu Hamasaki, Takashi Kakuta, Hatsue Ishibashi-Ueda, Yorihiko Matsumoto, Yuto Kumai, Kyoichi Wada, Keiichiro Iwasaki, Hiromi Takenaka, Shin Yajima, Yuki Kimura, Eiji Anegawa, Osamu Seguchi, Koichi Yoshitake, Junjiro Kobayashi, Yasumori Sujino, Norihide Fukushima, Hiroki Mochizuki, Kensuke Kuroda, Megumi Ikura, Tomoyuki Fujita, Nobuichiro Yagi, Kazuki Nakagita, Takuya Watanabe, Naoki Tadokoro, Koichi Toda
Publikováno v:
Circulation Journal. 84:2212-2223
Background Appropriate indications and protocols for induction therapy using basiliximab have not been fully established in heart transplant (HTx) recipients. This study elucidated the influence of induction therapy using basiliximab along with delay
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71f94ca06f8dbcfadd6607f9651adbf9
https://doi.org/10.1253/circj.cj-20-0164
https://doi.org/10.1253/circj.cj-20-0164
Autor:
Megumi Ikura, Kazuki Nakagita, Takaya Uno, Hiromi Takenaka, Sachi Matsuda, Miho Yoshii, Rikako Nagata, Ichiro Nakakura, Naoki Hayakawa, Tsutomu Nakamura, Kyoichi Wada, Osamu Seguchi
Publikováno v:
Heart Transplantation-New Insights in Therapeutic Strategies
At the National Cerebral and Cardiovascular Center, Japan, pharmacists have been involved in drug treatment management and patient care as members of multidisciplinary heart transplant teams that include surgeons, physicians, recipient transplant coo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::915c3208fbe249dbaf3335f36305e8ce
https://mts.intechopen.com/articles/show/title/role-of-the-transplant-pharmacist
https://mts.intechopen.com/articles/show/title/role-of-the-transplant-pharmacist
Autor:
Akira Oita, Kazuki Nakagita, Mitsutaka Takada, Sachi Matsuda, Takaya Uno, Hiromi Takenaka, Yutaro Mukai, Nobue Terakawa, Kyoichi Wada, Ryoji Nishino
Publikováno v:
European Journal of Clinical Pharmacology. 74:885-894
This study aimed to investigate relationships between times in therapeutic range (TTR) or warfarin sensitivity indexes (WSI) and VKORC1-1639GA and CYP2C9 polymorphisms in patients with left ventricular assist devices (LVAD).Severe heart failure patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::045a16123e296335a79b0720a9575def
https://doi.org/10.1007/s00228-018-2483-8
https://doi.org/10.1007/s00228-018-2483-8
Publikováno v:
International Journal of Medical Sciences
A historical cohort analysis of the Japan medical data center (JMDC) claims databases was performed to compare the incidence rates of bleeding events with warfarin (WF) versus direct oral anticoagulant (DOAC) treatment in patients with non-valvular a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d645a58422f7f1837e2dde18b576780
https://doi.org/10.7150/ijms.28877
https://doi.org/10.7150/ijms.28877
Autor:
Mai Fujimoto, Mitsutaka Takada, Takeshi Kuwahara, Kouichi Hosomi, Kengo Kusano, Koji Miyamoto, Yutaro Mukai, Kazuki Nakagita, Akira Oita, Kyoichi Wada
Publikováno v:
Journal of Arrhythmia, Vol 33, Iss 5, Pp 434-439 (2017)
Journal of Arrhythmia
Journal of Arrhythmia
Background The periprocedural protocol for atrial fibrillation (AF) ablation commonly includes anticoagulation therapy. Apixaban, a direct oral anticoagulant, is currently approved for clinical use; however, little is known about the effects of resid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1258566bcdcc9442259351cc7a4ac436
http://www.sciencedirect.com/science/article/pii/S1880427617301230
http://www.sciencedirect.com/science/article/pii/S1880427617301230
Autor:
Mitsutaka Takada, Kazuki Nakagita, Sachi Matsuda, Akira Oita, Nobue Terakawa, Kyoichi Wada, Yuka Terada
Publikováno v:
International journal of clinical pharmacology and therapeutics. 56(6)
Objective Everolimus is an inhibitor of the mammalian target of rapamycin (mTOR) and has been used in combination with calcineurin inhibitors (tacrolimus and cyclosporine) to prevent allograft rejection following organ transplantation. In heart trans
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d483fd643b15514874e921d982ee75d
https://pubmed.ncbi.nlm.nih.gov/29648533
https://pubmed.ncbi.nlm.nih.gov/29648533
Autor:
Norihide Fukushima, Sachi Matsuda, Mitsutaka Takada, Maya Takayoshi, Seiko Nakajima, Yuka Terada, Kazuki Nakagita, Osamu Seguchi, Kyoichi Wada, Masanobu Yanase, Takuma Sato, Haruki Sunami, Aki Shionoiri, Kensuke Kuroda, Akira Oita
Publikováno v:
International journal of clinical pharmacology and therapeutics. 56(4)
Objective Tuberculosis is an important concern following organ transplantation. Unfortunately, several antituberculosis drugs interact with immunosuppressants. This report describes our experience with rifabutin (RBT) in the treatment of acute tuberc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7609429751cb52c509ad8a7bc135822
https://pubmed.ncbi.nlm.nih.gov/29350178
https://pubmed.ncbi.nlm.nih.gov/29350178